CG MED EQUIP.
838810
BEOKA
870199
Shenzhen Bromake New Material
301387
4
Zhejiang Hongchang Electrical Technology
301008
5
Wuhan Lincontrol Automotive Electronics Co., Ltd.
688667
(Q3)Dec 31, 2024 | (Q2)Sep 30, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 399.87%4.71M | 1,435.66%5.54M | -533.90%-7.62M | -104.73%-208K | 252.04%4.4M | 4.63M | -259.43%-1.57M | 27.83%-415K | 182.59%1.76M | 123.17%1.25M |
Net income from continuing operations | 4.60%-3.51M | 620.52%15.5M | -567.85%-22.31M | -50.04%-8.52M | 15.98%-5.68M | ---3.79M | -59.67%-3.67M | -2,422.88%-2.98M | 262.88%4.77M | 47.09%-6.75M |
Depreciation and amortization | -3.29%2.35M | -344.06%-5.53M | 362.83%10.34M | -79.43%1.94M | 14.32%9.45M | --2.52M | 20.26%2.43M | 10.81%2.27M | 6.89%2.23M | -3.40%8.26M |
Deferred tax | -340.22%-663K | -3,604.76%-736K | 170.82%1.02M | 1,716.67%97K | -100.85%-6K | ---680K | -64.16%276K | -47.50%21K | 153.63%377K | -62.50%708K |
Other non cash items | -193.83%-639K | -356.83%-1.05M | 132.82%2.14M | 110.88%662K | -275.53%-6.08M | ---640K | -8.71%681K | -46.96%410K | -637.70%-6.53M | 8.01%3.47M |
Change In working capital | 260.75%4.76M | 204.24%2.04M | -4,463.40%-6.98M | 871.30%3.55M | 94.88%-460K | --4.61M | -60.86%-2.96M | 55.45%-1.96M | 94.02%-153K | 24.61%-8.99M |
-Change in receivables | 153.28%1.58M | 464.67%3.11M | -955.58%-6.97M | 151.10%746K | -6.73%-1.46M | --1.55M | -2,504.39%-2.97M | 64.17%-852K | 252.91%815K | 85.67%-1.37M |
-Change in inventory | 121.43%517K | -459.64%-1.4M | -163.29%-624K | 141.65%726K | 61.03%-1.74M | --517K | -1,700.00%-2.41M | 111.17%389K | 87.71%-237K | 24.73%-4.47M |
-Change in prepaid assets | 411.32%825K | 404.50%1.57M | -903.17%-1.52M | -282.05%-1.44M | 196.94%791K | --556K | 24.07%-265K | -66.38%311K | 114.14%189K | 71.47%-816K |
-Change in payables and accrued expense | 6.34%3.16M | -146.88%-3.4M | 1,434.49%4.99M | -8.19%4.06M | 868.52%4.42M | --3.2M | 2,899.06%2.97M | -227.95%-1.38M | -146.23%-374K | -107.19%-575K |
-Change in other current liabilities | -52.43%-910K | 50.77%-320K | -33.57%-927K | 75.66%-694K | -4.09%-2.85M | ---910K | 14.59%-597K | 7.67%-650K | -9.98%-694K | 1.83%-2.74M |
-Change in other working capital | -229.71%-406K | 1,014.35%2.49M | -1,404.73%-1.93M | -60.16%153K | -60.86%384K | ---300K | 171.14%313K | 32.74%223K | -86.05%148K | -19.79%981K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 399.87%4.71M | 1,435.66%5.54M | -533.90%-7.62M | -104.73%-208K | 252.04%4.4M | --4.63M | -259.43%-1.57M | 27.83%-415K | 182.59%1.76M | 123.17%1.25M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -16.39%-1.83M | -1,053.37%-23.13M | 187.01%19.64M | -224.26%-1.9M | 124.15%1.53M | -1.74M | 21.13%-1.57M | -42.91%-2.01M | 1,221.64%6.84M | -109.12%-6.33M |
Capital expenditure reported | -16.39%-1.83M | 319.75%4.41M | -343.48%-7.89M | 73.21%-1.9M | -13.85%-7.09M | ---1.74M | 21.13%-1.57M | -42.91%-2.01M | -191.80%-1.78M | -105.81%-6.23M |
Net PPE purchase and sale | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Net business purchase and sale | --0 | ---27.53M | 215.65%27.53M | --0 | --8.72M | --0 | --0 | --0 | --8.72M | --0 |
Net investment purchase and sale | ---- | ---- | ---- | --0 | 0.00%-100K | --0 | --0 | --0 | ---100K | ---100K |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -16.39%-1.83M | -1,053.37%-23.13M | 187.01%19.64M | -224.26%-1.9M | 124.15%1.53M | ---1.74M | 21.13%-1.57M | -42.91%-2.01M | 1,221.64%6.84M | -109.12%-6.33M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -721.25%-2.36M | 28,584.29%89.5M | -6,411.64%-89.47M | 2,604.61%92.82M | -1,214.18%-3.71M | -2.36M | -224.78%-287K | -66.27%312K | 18.12%-1.37M | -101.74%-282K |
Net issuance payments of debt | -231.55%-1.23M | -194.32%-1.33M | 375.79%3.67M | 43,087.04%92.85M | -204.23%-216K | ---1.23M | 293.25%932K | 51.40%1.41M | 11.16%-1.33M | 98.81%-71K |
Net common stock issuance | 96.67%-3K | 68,650.00%2.74M | -6,345.45%-2.84M | 78.01%-31K | 33.18%-141K | ---3K | -1,185.71%-90K | 20.00%-4K | 75.69%-44K | -100.81%-211K |
Cash dividends paid | 0.09%-1.13M | --88.05M | ---90.3M | --0 | ---3.39M | ---1.13M | ---1.13M | ---- | ---- | --0 |
Proceeds from stock option exercised by employees | --0 | --36K | --0 | --0 | --36K | --0 | --0 | ---- | ---- | --0 |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -721.25%-2.36M | 28,584.29%89.5M | -6,411.64%-89.47M | 2,604.61%92.82M | -1,214.18%-3.71M | ---2.36M | -224.78%-287K | -66.27%312K | 18.12%-1.37M | -101.74%-282K |
Net cash flow | ||||||||||
Beginning cash position | -11.03%19.61M | 25.13%31.39M | 509.62%109.66M | 7.47%19.33M | -32.78%17.99M | --19.61M | 22.35%22.04M | 20.23%25.09M | -32.78%17.99M | 45.16%26.76M |
Current changes in cash | 115.52%532K | 3,511.43%71.91M | -1,172.24%-77.45M | 3,986.17%90.71M | 141.39%2.22M | --532K | -343.91%-3.43M | -100.19%-2.11M | 263.68%7.22M | -168.81%-5.36M |
Effect of exchange rate changes | -181.02%-807K | 192.90%876K | -569.11%-823K | 56.56%-381K | 74.27%-877K | ---807K | 536.84%996K | 47.67%-943K | 91.69%-123K | -741.81%-3.41M |
End cash Position | -1.40%19.33M | -11.03%19.61M | 25.13%31.39M | 467.27%109.66M | 7.47%19.33M | --19.33M | 15.25%19.61M | 22.35%22.04M | 20.23%25.09M | -32.78%17.99M |
Free cash flow | 192.01%2.89M | 511.12%9.95M | -61,936.00%-15.51M | 21.81%-2.11M | 45.87%-2.7M | --2.89M | -213.37%-3.14M | -22.35%-2.42M | 99.09%-25K | 40.82%-4.98M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion |